Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Roche Products Limited
Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 23/12/2011
PIL MabThera 100mg and 500mg concentrate for solution for infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/12/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 21/09/2011 and displayed until 23/12/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 08/11/2010 and displayed until 21/09/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 31/03/2010 and displayed until 08/11/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 16/09/2009 and displayed until 31/03/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 02/09/2009 and displayed until 16/09/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/02/2009 and displayed until 02/09/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 12/12/2008 and displayed until 26/02/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/07/2008 and displayed until 12/12/2008
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to storage instructions
Updated on 01/07/2008 and displayed until 23/07/2008
Reasons for adding or updating:
  • Change of contra-indications
Updated on 31/01/2008 and displayed until 01/07/2008
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Active Ingredients/Generics

 
  rituximab